Cargando…

Drug-Drug Interaction Analysis of Pyronaridine/Artesunate and Ritonavir in Healthy Volunteers

A multiple dose, parallel group study was conducted to assess for a drug-drug interaction between the pyronaridine/artesunate (PA) combination antimalarial and ritonavir. Thirty-four healthy adults were randomized (1:1) to receive PA for 3 days or PA with ritonavir (100 mg twice daily for 17 days, P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morris, Carrie A., Lopez-Lazaro, Luis, Jung, Donald, Methaneethorn, Janthima, Duparc, Stephan, Borghini-Fuhrer, Isabelle, Pokorny, Rolf, Shin, Chang-Sik, Fleckenstein, Lawrence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284369/ https://www.ncbi.nlm.nih.gov/pubmed/22403324 http://dx.doi.org/10.4269/ajtmh.2012.11-0558

Ejemplares similares

Pharmacokinetic Interaction between Pyronaridine-Artesunate and Metoprolol
por: Morris, Carrie A., et al.
Publicado: (2014)

Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients
por: Ayyoub, Amal, et al.
Publicado: (2016)

Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials
por: Duparc, Stephan, et al.
Publicado: (2013)

Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
por: Morris, Carrie A, et al.
Publicado: (2011)

Review of pyronaridine anti-malarial properties and product characteristics
por: Croft, Simon L, et al.
Publicado: (2012)

Pyronaridine-Artesunate versus Chloroquine in Patients with Acute Plasmodium vivax Malaria: A Randomized, Double-Blind, Non-Inferiority Trial
por: Poravuth, Yi, et al.
Publicado: (2011)

Efficacy and Safety of Pyronaridine–Artesunate for the Treatment of Uncomplicated Plasmodium falciparum and Plasmodium vivax Malaria in Myanmar
por: Han, Kay Thwe, et al.
Publicado: (2020)

Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial
por: Kayentao, Kassoum, et al.
Publicado: (2012)

Efficacy, Safety and Tolerability of Pyronaridine-artesunate in Asymptomatic Malaria-infected Individuals: a Randomized Controlled Trial
por: Dabira, Edgard D, et al.
Publicado: (2021)

Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trial
por: Groger, Mirjam, et al.
Publicado: (2022)

Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial
por: Sagara, Issaka, et al.
Publicado: (2016)

Pyronaridine–artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study
por: Tona Lutete, Gaston, et al.
Publicado: (2021)

Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria
por: Pryce, Joseph, et al.
Publicado: (2019)

Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria
por: Pryce, Joseph, et al.
Publicado: (2022)

Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria
por: Bukirwa, Hasifa, et al.
Publicado: (2014)

Pharmacokinetic Interactions between Primaquine and Pyronaridine-Artesunate in Healthy Adult Thai Subjects
por: Jittamala, Podjanee, et al.
Publicado: (2014)

Plasmodium falciparum gametocyte dynamics after pyronaridine–artesunate or artemether–lumefantrine treatment
por: Roth, Johanna M., et al.
Publicado: (2018)

Efficacy and safety of pyronaridine-artesunate (Pyramax(®)) for the treatment of uncomplicated Plasmodium vivax malaria in Northwest Ethiopia
por: Mohammed, Hussein, et al.
Publicado: (2022)

Application of Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung and Trachea Exposure of Pyronaridine and Artesunate in Hamsters
por: Kang, Dong Wook, et al.
Publicado: (2023)

Environmentally Responsible and Cost-Effective Synthesis of the Antimalarial Drug Pyronaridine
por: Kincaid, Joseph R. A., et al.
Publicado: (2022)

Therapeutic efficacy of pyronaridine-artesunate (Pyramax(®)) against uncomplicated Plasmodium falciparum infection at Hamusit Health Centre, Northwest Ethiopia
por: Alebachew, Mihreteab, et al.
Publicado: (2023)

Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects
por: Tan, Beesan, et al.
Publicado: (2009)

Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine–artesunate in a rural health district in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022)

Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review
por: Drysdale, Myriam, et al.
Publicado: (2022)

Pyronaridine–artesunate and artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial
por: Roth, Johanna M., et al.
Publicado: (2018)

Pharmacokinetic Outcomes of the Interactions of Antiretroviral Agents with Food and Supplements: A Systematic Review and Meta-Analysis
por: Siritientong, Tippawan, et al.
Publicado: (2022)

Global gene expression profiling of Plasmodium falciparum in response to the anti-malarial drug pyronaridine
por: Kritsiriwuthinan, Kanyanan, et al.
Publicado: (2011)

Medication selection for the treatment of acute infective diarrhea in Thai pharmacies: a qualitative study
por: Leelakanok, Nattawut, et al.
Publicado: (2021)

Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults
por: Rattanapunya, Siwalee, et al.
Publicado: (2015)

In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays
por: Kurth, Florian, et al.
Publicado: (2009)

Old drug repurposing for neglected disease: Pyronaridine as a promising candidate for the treatment of Echinococcus granulosus infections
por: Li, Jun, et al.
Publicado: (2020)

Efficacy and safety of pyronaridine–artesunate versus artemether–lumefantrine in the treatment of acute uncomplicated malaria in children in South-West Nigeria: an open-labelled randomized controlled trial
por: Falade, Catherine O., et al.
Publicado: (2023)

Optimal dose finding for novel antimalarial combination therapy*
por: Duparc, S, et al.
Publicado: (2012)

Pharmacokinetic Interaction Between Prasugrel and Ritonavir in Healthy Volunteers
por: Ancrenaz, Virginie, et al.
Publicado: (2013)

Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers
por: Orrell, Catherine, et al.
Publicado: (2008)

Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria
por: Morris, Carrie A, et al.
Publicado: (2011)

Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice
por: SheelaNair, Arya, et al.
Publicado: (2022)

The wisdom of crowds and the repurposing of artesunate as an anticancer drug
por: Augustin, Yolanda, et al.
Publicado: (2015)

After morning, phew! A knowledge, attitudes, and practices survey related to emergency oral contraception in Thai pharmacists
por: Leelakanok, Nattawut, et al.
Publicado: (2023)

Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine
por: Vignaux, Patricia A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a3cj3b4jmgcs2u34sp9ij4f8ss